839712-15-1 ((Desmethyl cariprazine)

CAS号:
839712-15-1
英文名称:
Desmethyl cariprazine
分子式:
C20H30Cl2N4O
分子量:
413.384402751923
简介:
Desmethyl cariprazine 是 Cariprazine 的活性代谢产物。Cariprazine,是抗精神病有效剂候选活性分子,结合 D3, D2 和 5-HT1A 的 Ki 为 0.085 nM,0.49 nM,2.6 nM。

Desmethyl cariprazine(839712-15-1)名称与标识符

名称

英文别名:
Desmethyl cariprazine;286RCD7025;Urea, N-(trans-4-(2-(4-(2,3-dichlorophenyl)-1-piperazinyl)ethyl)cyclohexyl)-N'-methyl-;Dcar;1-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-3-methylurea;Q27254272;N-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N′-methylurea (ACI);SCHEMBL3406923;DA-72685;HY-100656;CS-0019895;MS-27144;SCHEMBL3406924;N-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N'-methyl Urea;839712-15-1;G17868;AKOS040741624;UNII-286RCD7025;

标识符

InChIKey:
WMQLLTKSISGWHQ-UHFFFAOYSA-N
Inchi:
1S/C20H30Cl2N4O/c1-23-20(27)24-16-7-5-15(6-8-16)9-10-25-11-13-26(14-12-25)18-4-2-3-17(21)19(18)22/h2-4,15-16H,5-14H2,1H3,(H2,23,24,27)
SMILES:
ClC1C(=CC=CC=1N1CCN(CC1)CCC1CCC(CC1)NC(NC)=O)Cl

Desmethyl cariprazine(839712-15-1)物化性质

计算特性

  • 精确分子量 : 412.1796670g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 5
  • 同位素质量 : 412.1796670g/mol
  • 重原子数量 : 27
  • 复杂度 : 465
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 4.1
  • 拓扑分子极性表面积 : 47.6

Desmethyl cariprazine(839712-15-1)推荐厂家 更多厂家(9)

Desmethyl cariprazine(839712-15-1)合成路线

合成路线:1 步
反应条件:
参考文献:
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Gogarnoiu, Emma S. ; et al, Journal of Medicinal Chemistry, 2023, 66(3), 1809-1834
合成路线:2 步
反应条件:
参考文献:
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Gogarnoiu, Emma S. ; et al, Journal of Medicinal Chemistry, 2023, 66(3), 1809-1834
合成路线:3 步
反应条件:
参考文献:
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Gogarnoiu, Emma S. ; et al, Journal of Medicinal Chemistry, 2023, 66(3), 1809-1834
合成路线:4 步
反应条件:
参考文献:
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Gogarnoiu, Emma S. ; et al, Journal of Medicinal Chemistry, 2023, 66(3), 1809-1834
合成路线:5 步
反应条件:
参考文献:
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Gogarnoiu, Emma S. ; et al, Journal of Medicinal Chemistry, 2023, 66(3), 1809-1834